• OKYO Pharma will present at the Ophthalmology Futures European Forum on Sept. 10, 2026 in London.
• It will also present at ESCRS iNovation Day on Sept. 11, 2026 at ExCeL London, alongside the ESCRS Congress.
• Conference appearances come as urcosimod advances in the global Phase 3 NEPTUNE pivotal trial for neuropathic corneal pain.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OKYO Pharma Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609090700OMX_____CNEWS_EN_GNW9823642_en) on September 09, 2026, and is solely responsible for the information contained therein.